Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Antimicrobial Resistance and Infection Control
|
May 24, 2016
Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys
Geoffrey Taylor, Denise Gravel, Anne Matlow, et al.
Emerging Infectious Diseases
|
August 21, 2020
Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013-2018
Melissa McCracken, Robyn Mitchell, Stephanie Smith, et al.
Diabetes/Metabolism Research and Reviews
|
September 20, 2015
IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes
Benjamin A Lipsky, Javier Aragón-Sánchez, Mathew Diggle, et al.
Expert Review of Anti-Infective Therapy
|
April 20, 2012
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, et al.
Drugs
|
February 11, 2016
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G Zhanel, Doris Cheung, Heather Adam, et al.
Jac-Antimicrobial Resistance
|
February 14, 2022
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19
Alyssa R Golden, Melanie R Baxter, James A Karlowsky, et al.
Expert Review of Anti-Infective Therapy
|
September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2013
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
George G Zhanel, Heather J Adam, Melanie R Baxter, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Journal of Global Antimicrobial Resistance
|
February 4, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Antimicrobial Resistance and Infection Control
|
May 24, 2016
Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys
Geoffrey Taylor, Denise Gravel, Anne Matlow, et al.
Emerging Infectious Diseases
|
August 21, 2020
Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013-2018
Melissa McCracken, Robyn Mitchell, Stephanie Smith, et al.
Diabetes/Metabolism Research and Reviews
|
September 20, 2015
IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes
Benjamin A Lipsky, Javier Aragón-Sánchez, Mathew Diggle, et al.
Expert Review of Anti-Infective Therapy
|
April 20, 2012
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
George G Zhanel, Christopher D Lawson, Sheryl Zelenitsky, et al.
Drugs
|
February 11, 2016
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G Zhanel, Doris Cheung, Heather Adam, et al.
Jac-Antimicrobial Resistance
|
February 14, 2022
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19
Alyssa R Golden, Melanie R Baxter, James A Karlowsky, et al.
Expert Review of Anti-Infective Therapy
|
September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2013
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
George G Zhanel, Heather J Adam, Melanie R Baxter, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Journal of Global Antimicrobial Resistance
|
February 4, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Page
of 14